Cleveland Clinic Adopts New Robotic Heart Valve Surgery

The procedure uses a small neck incision to replace aortic valves, helping patients avoid breastbone-splitting surgery.

Updated on Oct. 16, 2026 in Heart Disease

Isometric editorial illustration of a surgical robotic arm, representing clinical precision in new heart valve replacement technology. — The Cleveland Clinic has begun using the CardioPrecision robotic platform for aortic valve replacement, allowing surgeons to operate through a neck incision. AI Illustration. Upload story photo >

Live Poll

Would you trust a robotic surgical procedure over traditional open-heart surgery for your own care?

The Cleveland Clinic has adopted the CardioPrecision robotic surgery platform for routine use in transcervical aortic valve replacement. This new technology, known as the AVATAR procedure, allows surgeons to perform valve replacements through a small neck incision rather than splitting the breastbone.

Why it matters

By eliminating the need to divide the breastbone, the AVATAR procedure aims to reduce pain and accelerate patient recovery times compared to traditional open-heart surgery methods. This shift reflects a broader commitment to precision medicine and less invasive care options for patients in Cleveland.

The Cleveland Clinic reports a 50% increase in robotic-assisted cardiothoracic operations during the first half of 2026 compared to the previous year, reaching a milestone of 3,000 total procedures. It remains unknown how specific patient outcomes for this new platform compare to existing standards.

The players

Cleveland Clinic

An academic medical center known for high-volume heart surgery and the adoption of advanced robotic systems.

The details

The AVATAR procedure uses the CardioPrecision platform to access the heart through a small incision in the neck, avoiding the invasive sternotomy required in conventional aortic valve replacement. The system integrates its CoreVista Robot Enabling Platform with existing robotic surgical systems like the da Vinci Xi and da Vinci 5 to improve technical precision during these specialized operations.

The Cleveland Clinic saw a 50% increase in robotic-assisted cardiothoracic surgeries during the first half of 2026.
A cumulative total of 3,000 robotic-assisted cardiothoracic surgeries was reached by mid-2026.
The adoption of the platform for routine clinical use was announced in October 2026.
The global robotic-assisted surgery market is projected to reach £34 billion by 2033.

Health Landscape

The integration of this technology follows the growth of the global robotic-assisted surgery market, currently valued at £13 billion. This development marks a transition toward minimally invasive robotic techniques in cardiac care, moving beyond the traditional surgical approaches used for decades.

Patients in Cleveland needing aortic valve replacement may consider discussing the benefits and risks of the AVATAR procedure with their cardiothoracic surgeon. This minimally invasive option is worth investigating for those seeking alternatives that prioritize reduced pain and faster recovery times.

The takeaway

Robotic surgical platforms are increasingly transforming cardiac care by offering less invasive access to the heart. Patients should consult with their surgical team to understand if minimally invasive robotic options are appropriate for their specific health needs.